NCT01725074

Brief Summary

This randomized controlled trial (RCT) will examine a case management program for patients suffering from coronary heart disease with multimorbidity in Mannheim, Germany. The trail consists of 3 treatment arms: 1) intensified case management; 2) social interaction alone 3) standard care. The main objectives are to evaluate how case management and social interaction alone compared to standard medical care affect the primary and secondary outcomes: physical health, quality of life, loneliness, depression, self-efficacy, outcome expectancies, social support, health locus of control, lifestyle behavior, social network, vulnerability, intention, severity, health worries and cognitive functions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2011

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 8, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 12, 2012

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

November 12, 2012

Status Verified

November 1, 2012

Enrollment Period

1.4 years

First QC Date

November 8, 2012

Last Update Submit

November 9, 2012

Conditions

Keywords

Coronary Heart Disease, multimorbidity, primary care, case management, loneliness, depression, social support

Outcome Measures

Primary Outcomes (2)

  • Change in health outcomes

    This includes biomarkers (blood pressure, BMI, weight, blood lipids), physical balance performance (semi tandem stand), care utilization and medication usage, clinical assessments and need for (medical) treatment (like dyspnea, fatigue, care, vomitus, thirst, lack of appetite, nausea, disorientation). Within the intervention group CM CHD weight and blood pressure is self-reported by patients biweekly within the first six months and monthly within the second six months.

    Measured at baseline, 6 and 12 months follow-up

  • Change in quality of life

    We will measure this variable using the "EQ-5D" and two additional items.

    Measured at baseline, 6 and 12 months follow-up

Secondary Outcomes (13)

  • Change in Loneliness

    Measured at baseline, 6 and 12 months follow-up

  • Change in Depression

    Measured at baseline, 6 and 12 months follow-up

  • Change in self-efficacy

    Measured at baseline, 6 and 12 months follow-up

  • Change in social support

    Measured at baseline, 6 and 12 months follow-up

  • Change in health locus of control

    Measured at baseline, 6 and 12 months follow-up

  • +8 more secondary outcomes

Study Arms (3)

Case Management "CM CHD"

EXPERIMENTAL

The intervention consists of a biweekly telephone or personal contact by trained case managers over the first 6-months and monthly contact over the second 6-months to assess well-being, everyday life (positive, neutral and negative daily events), and to inquire after health and personal problems on which basis the case manager offers practical or emotional support or a referral to the general practitioner if deemed necessary. During the contacts also medical control measures like blood pressure or weight are taken, and other study outcome measures like need for medical treatment.

Behavioral: Case Management "CM CHD"

Social Interaction

EXPERIMENTAL

Identical as the CM CHD group, but with exclusion of medical control measures.

Behavioral: Social Interaction

Control Group

NO INTERVENTION

Patients assigned to the control group received usual care (no additional contact/support) and therefore stays under the standard supervision of the general practitioner i.e. as participant in the normal disease management program for CHD (quarterly check-ups).

Interventions

Patients, who are randomized to the intervention group, will receive case management from a trained and experienced physician assistant. The case manager will carry out following tasks: * Biweekly/monthly telephone consultations or home visits * Identification of health or personal problems of the patient * Monitoring of medical parameters * Coordination of contact with health care providers if necessary * Support to the patient related to health status and environmental changes * Promote disease-self management through coaching * Counseling, that is focused on emotional support and active listening

Case Management "CM CHD"

Identical as the CM CHD group, but with exclusion of medical control measures and the medical aspects.

Social Interaction

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed CHD
  • participation in the Disease Management Program (DMP) of CHD or
  • a risk score (Framingham or Procam) higher than 20%
  • two additional chronic diseases (multimorbid)

You may not qualify if:

  • Patients living in institutionalized care
  • Patients having dementia
  • Patients associated with a life expectancy of less than one year
  • Patients who are not able to communicate in German language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Genossenschaft Gesundheitsprojekt Mannheim e.G.

Mannheim, Baden-Wurttemberg, 68259, Germany

Location

MeSH Terms

Conditions

Coronary DiseaseDepression

Interventions

Drug Interactions

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Pharmacological PhenomenaPharmacological and Toxicological PhenomenaPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2012

First Posted

November 12, 2012

Study Start

July 1, 2011

Primary Completion

December 1, 2012

Study Completion

March 1, 2013

Last Updated

November 12, 2012

Record last verified: 2012-11

Locations